A blood test that can detect breast cancer is expected to begin clinical trials within three years

A blood test that can detect breast cancer is expected to begin clinical trials within three years

Author: AAP

Published: 13-05-2019

Clinical trials for a blood test designed to detect breast cancer are expected to begin within the next three years.

A blood test that can detect breast cancer is expected to begin clinical trials within three years.

The test, developed by Olivia Newton-John Cancer Research Institute researchers, checks breast cancer patients' blood for DNA specific to tumours, News Corp Australia reports.

The research has been awarded a $385,000 National Breast Cancer Foundation grant.

Initially the test will be used to check women who have already been treated for breast cancer for the return of the disease.

FEATURED JOBS

EOI- Mental Health professionals

Talent Quarter PTY Ltd

EOI- Mental Health professionals

Talent Quarter PTY Ltd

EOI- Mental Health professionals

Talent Quarter PTY Ltd

Sonographer - Gold Coast

South Coast Radiology

Associate Professor Alexander Dobrovic from the Olivia Newton-John Cancer Research Institute said there was the potential for the test to be modified so it could be used in the early detection of breast cancer.

"To be truly effective as a screening test, it would have to be refined so it could identify all women who have cancer," he told News Corp Australia.

Comments

Thanks, you've subscribed!

Share this free subscription offer with your friends

Forgot Password

Sign In

Register

Company Information

Billing Address

Are you primarily interested in advertising *

Do you want to recieve the HealthTimes Newsletter?